Although these cancers share common RASGAP pathway components, such as DAB2IP, the extent of pathway involvement and its functional significance can differ due to variations in molecular context, tumor biology, and genetic alterations (Figure 2). This evidence concerns the gene DAB2IP and neoplasm.